Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
Washington University School of Medicine
UNICANCER
Gene Surgery LLC
Dana-Farber Cancer Institute
Umeå University
Xencor, Inc.
National Institutes of Health Clinical Center (CC)
Institut de Cancérologie de Lorraine
Xencor, Inc.
Institut de Cancérologie de Lorraine
Boston Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Oryx GmbH & Co. KG
Traws Pharma, Inc.
Eli Lilly and Company
OHSU Knight Cancer Institute
Stanford University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Trans Tasman Radiation Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center